PREPARATION FOR PREVENTING AND TREATING OCULAR DISEASE ACCOMPANIED BY OPTIC NERVE DISORDER Russian patent published in 2013 - IPC A61K31/41 A61P27/06 

Abstract RU 2491066 C2

FIELD: medicine.

SUBSTANCE: group of inventions refers to ophthalmology. The group of inventions discloses the pharmaceutical use of 2-phenyl-1,2-benzisoselenazol-3(2H)-one or a salt thereof effective as an agent for preventing or treating an ocular disease accompanied by an optic nerve disorder which represents glaucoma, glaucomatous optic nerve neuropathy or glaucomatous visual field constriction. The preparation is a dosage form of eye drops, ophthalmic ointments, an insert, a dressing, an injection, a tablet, a delayed release granule or a capsule. The mode of introduction represents introduction into a vitreous body, a conjunctival sac, instillations, subconjunctival, sub-Tenon's or oral introduction.

EFFECT: group of inventions provides a suppressive effect on the retinal ganglion cell protection.

12 cl, 3 tbl, 4 ex

Similar patents RU2491066C2

Title Year Author Number
GLAUCOMA TREATMENT 2018
  • Bruce Lars
  • Bruce Adam
RU2759998C2
AGENTS ADJUSTING, INHIBITING OR MODULATING ACTIVITY AND/OR EXPRESSION OF CONNECTIVE TISSUE GROWTH FACTORS (CTGF) AS UNIQUE DRUGS FOR INTRAOCULAR TENSION REDUCTION AND TREATMENT OF GLAUCOMA RETINOPATHIES/OPTICAL NEUROPATHIES 2003
  • Flinor Debra L.
  • Shepard Allan
  • Dzhejkobson Nasrin
  • Pan Iok-Khou
  • Klark Ehbbot F.
RU2332213C2
METHOD FOR TREATMENT OF GLAUCOMOUS OPTIC NEUROPATHY BY MEANS OF TRANSPLANTATION OF 3D CELLULAR CULTURE OF MULTIPOTENT MESENCHIMAL SCLERAL SULCUS STEM CELLS 2016
  • Borzenok Sergej Anatolevich
  • Khubetsova Madina Khetagovna
  • Komakh Yurij Alekseevich
  • Ostrovskij Dmitrij Sergeevich
  • Tonaeva Khadizhat Dzhankhuvatovna
  • Gavrilova Natalya Aleksandrovna
  • Lanevskaya Nataliya Iosifovna
RU2623646C1
METHOD FOR EARLY DIAGNOSIS OF LOW-TENSION GLAUCOMA 2023
  • Zagidullina Aigul Shamilevna
  • Arslanova Aigul Irekovna
  • Galimova Venera Uzbekovna
  • Mukhamadeev Timur Rafaelevich
RU2816038C1
METHOD OF COMBINED TREATMENT OF GLAUCOMATOUS OPTIC NEUROPATHY 2010
  • Dzhumova Marina Fedorovna
  • Marchenko Ljudmila Nikolaevna
  • Fedulov Aleksandr Sergeevich
  • Dzhumova Anna Anatol'Evna
  • Frolov Mikhail Aleksandrovich
RU2472475C2
APPLICATION OF SERUMAL AMYLOID GENE A IN DIAGNOSTICS AND TREATMENT OF GLAUCOMA AND DETERMINATION OF ANTIGLAUCOMA AGENTS 2004
  • Klark Ehbbot F.
  • Van Van'-Khehn
  • Maknatt Loretta
RU2365379C2
ANTAGONISTS CDK2 AS ANTAGONISTS OF SHORT FORM OF C-MAF TRANSCRIPTION FACTOR FOR GLAUCOMA TREATMENT 2004
  • Shepard Allan R.
  • Dzhejkobson Nasrin
  • Klark Ehbbot F.
RU2370267C2
APPLICATION OF SERUM AMYLOID A GENE FOR DIAGNOSIS AND THERAPY OF GLAUCOMA AND IDENTIFICATION OF ANTIGLAUCOMATOUS AGENT 2007
  • Klark Ehbbot F.
  • Van Van'-Khehn
  • Maknatt Loretta Grejvz
RU2461378C2
METHOD FOR PREDICTION OF PRIMARY OPEN-ANGLE GLAUCOMA 2012
  • Rukina Dar'Ja Aleksandrovna
  • Markelova Elena Vladimirovna
  • Dogadova Ljudmila Petrovna
  • Chikalovets Irina Vladimirovna
RU2483306C1
AGENT FOR USE IN TREATMENT OR PREVENTION OF OPHTHALMOLOGICAL DISORDERS 2020
  • Imbimbo, Bruno, Pietro
  • Villetti, Gino
RU2812055C1

RU 2 491 066 C2

Authors

Khirai Sin-Itiro

Sasaoka Masaaki

Sajke Khisajuki

Dates

2013-08-27Published

2009-02-27Filed